As many as four IPO are gearing up to hit the markets this week. These are Devyani International IPO, Exxaro Tiles IPO, Krsnaa Diagnostics IPO and Windlas Biotech IPO. All of these IPO start at August 4 and close on August 6. Zomato, Tatva Chintan Pharma Chem Limited, GR Infra and Life Science IPOs made a stellar debut on the stock exchanges in July. Let us find out all other details an investor would want to know about these IPOs 

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

See Zee Business Live TV Streaming Below:

1. Devyani International IPO Details 

Devyani International IPO open and close dates: August 4 and August 6, respectively 

Devyani International IPO issue size:  1,838-crore 

Devyani International IPO price band: Rs 86 to Rs 90  

Devyani International IPO Market Lot: 165 Shares 

Devyani International IPO Min Order Quantity: 165 Shares 

Devyani International IPO Book Running Lead Managers: Kotak Mahindra Capital Company, CLSA India, Edelweiss Financial Services and Motilal Oswal Investment Advisors  

*Devyani International is an associate company of RJ Corp, the largest bottling partner of food and beverages (F&B) major Pepsico, and has interests in the Indian retail F&B sector. It currently operates 297 Pizza Hut stores, 264 KFC stores and 44 Costa Coffee as on March 2021 in India. Proceeds from the fresh issue will be used to retire debt and general corporate purposes.  

2. Krsnaa Diagnostics IPO Details 

Krsnaa Diagnostics IPO opening and closing dates:  August 4 and August 6 respectively 

Krsnaa Diagnostics IPO issue size: Rs 1,213.33 crore 

Krsnaa Diagnostics IPO price band: Rs 933 to Rs 954 per equity share 

Krsnaa Diagnostics market lot:  15 Shares 

Krsnaa Diagnostics Min Order Quantity: 15 Shares 

*Krsnaa Diagnostics was incorporated in 2010 and is dubbed as one of the fastest-growing diagnostic chains in India. It offers its customer base a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and teleradiology services.  The proceed from the IPO will be utilized to finance the cost of establishing diagnostics centres at Punjab, Karnataka, Himachal Pradesh, and Maharashtra and will be used for general corporate purposes. 

3. Exxaro Tiles IPO Details 

Exxaro Tiles IPO Issue Period: Aug 4, August 6 

Exxaro Tiles IPO Issue Size: Initial Public offer of 13,424,000 Equity Shares a Fresh Issue of up to 11,186,000 Equity Shares and an Offer for Sale of up to 2,238,000 equity shares 

Exxaro Tiles IPO Price Range: Rs118 to Rs120 

Exxaro Tiles IPO Discount:  Rs12 per share for Eligible Employee Category 

Exxaro Tiles IPO Bid Lot:  125 Equity Shares and in multiples thereof 

Exxaro Tiles IPO Minimum Order Quantity: 125 Equity Shares 

Exxaro Tiles IPO Maximum Subscription Amount for Retail Investor: Rs 2,00,000 

Exxaro Tiles IPO Maximum Subscription Amount for Eligible Employee: Rs 5,00,000  

*Exxaro Tiles is a leading manufacturer of vitrified tiles. Promoted by Mukeshkumar Patel, Dineshbhai Patel, Rameshbhai Patel and Kirankumar Patel, Exxaro Tiles is primarily engaged in the business of manufacturing and marketing of vitrified tiles used majorly for flooring solutions catering to residential and commercial segments. Proceeds from the fresh issue would be utilised towards repaying/prepaying of borrowings, fund its working capital requirements besides utilising it for general corporate purposes.  

4. Windlas Biotech IPO Deatils 

Windlas Biotech IPO Issue Period:  04 August to 06 August 2021 

Windlas Biotech IPO Issue Size: Eq Shares of ₹5 (aggregating up to ₹401.54 Cr), Eq Shares of ₹5 (aggregating up to ₹400.00 Cr) of fresh issue and 8,525,520 Eq Shares of ₹5 (aggregating up to ₹813.33 Cr) for offer of sale

Windlas Biotech IPO Price Range: Rs 448 to Rs 460 

Windlas Biotech IPO Bid Lot: 30 Equity Shares and in multiples thereof 

Windlas Biotech IPO Minimum Order Quantity: 30 Equity Shares 

Windlas Biotech IPO Maximum Subscription Amount for Retail Investor: Rs. 2,00,000 

Windlas Biotech IPO IPO Market Timings: 10.00 a.m. to 5.00 p.m. 

Windlas Biotech IPO Book Running Lead Managers: SBI Capital Markets Limited, DAM Capital Advisors Limited, IIFL Securities Limited. 

*Windlas Biotech is a manufacturer of pharmaceutical formulations. The proceeds from the IPO will be utilised for purchasing of equipment required for capacity expansion of the facility at Dehradun Plant -IV and addition of injectables dosage capability at the facility at Dehradun Plant-II. It will also be used for funding incremental working capital requirements, repayment/ prepayment of certain of borrowings and general corporate purposes.  

(Inputs from NSE and PTI)